Chunmei Wang
Jilin, 132013, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Schisandrin B Alleviates Lipid Metabolism Disorders and Apoptosis of MAFLD via Modulation of PPARγ-PCK1 and Caspase-3 Signaling Pathways.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: August 23, 2025
Lycorine inhibits Ang II-induced heart remodeling and inflammation by suppressing the PI3K-AKT/NF-κB pathway.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: December 13, 2023
Inhibitory effects of Schisandrin C on collagen behavior in pulmonary fibrosis.
Journal: Scientific reports
Published: April 07, 2023
Molecular Mechanism of the Regulatory Effect of Schisandrol A on the Immune Function of Mice Based on a Transcription Factor Regulatory Network.
Journal: Frontiers in pharmacology
Published: September 30, 2021
Study on the Hepatoprotection of Schisandra chinensis Caulis Polysaccharides in Nonalcoholic Fatty Liver Disease in Rats Based on Metabolomics.
Journal: Frontiers in pharmacology
Published: June 19, 2021
Anwulignan alleviates d-galactose induced renal damage by regulating Nrf2/ARE signaling pathway in mice.
Journal: Food science and biotechnology
Published: June 04, 2020
Schisandrin B attenuates bleomycin-induced pulmonary fibrosis in mice through the wingless/integrase-1 signaling pathway.
Journal: Experimental lung research
Published: May 05, 2020
Schisandrin B inhibits TGF-β1-induced epithelial-mesenchymal transition in human A549 cells through epigenetic silencing of ZEB1.
Journal: Experimental lung research
Published: July 04, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026